Neoplasm
Not recruitingStudy on the Safety and Effectiveness of MK-1200 for Patients with Advanced Solid Tumors
Poland- Participants:18–64 years · 65+ years
- Substances:Mk-1200
- Sponsor:Merck Sharp & Dohme LLC
Rare diseases
Investigational molecules
Locations
Back to Poland1 210 clinical trials in Cracow, Poland across 18 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in PolandBadaniaKliniczne.pl(opens in a new tab)
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
Poland
PolandThe busiest research cities in the country
What the registry says about research in the country
Innovative studies focusing on respiratory infections and preventive measures. Current trials evaluate vaccines against RSV and human metapneumovirus in older adults, alongside investigations into chronic respiratory conditions.
Multiple trials are exploring novel therapeutic approaches for respiratory conditions affecting various age groups.
Comprehensive research into preventive vaccines for various conditions, including chickenpox and meningococcal infections. Studies focus on both pediatric and adult populations.
Research emphasizes vaccine safety, immune response, and efficacy across different age groups.
Advanced studies targeting chronic conditions including psoriatic arthritis and systemic diseases. Research focuses on innovative treatments and long-term management strategies.
Trials evaluate new therapeutic approaches for improving patient outcomes in chronic conditions.
Tell us about your condition – we search every trial in Europe and connect you with the right site.